Entourage Health (CVE:ENTG) Sets New 1-Year High – Still a Buy?

Entourage Health Corp. (CVE:ENTGGet Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as C$0.02 and last traded at C$0.02, with a volume of 12043 shares traded. The stock had previously closed at C$0.02.

Entourage Health Price Performance

The firm has a market cap of C$3.08 million, a price-to-earnings ratio of -0.11 and a beta of 1.08. The company has a debt-to-equity ratio of 2,914.72, a current ratio of 0.10 and a quick ratio of 0.91. The stock has a 50-day moving average price of C$0.01 and a 200 day moving average price of C$0.01.

Entourage Health Company Profile

(Get Free Report)

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.

See Also

Receive News & Ratings for Entourage Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entourage Health and related companies with MarketBeat.com's FREE daily email newsletter.